Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment with Indapamide in Patients with Post-Surgical Hypoparathyroidism (HYPOCARE TREAT)
2024-516000-41-01Phase 4Authorised
- Sponsor
- Central Denmark Region
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of indapamide in hypoparathyroidism (2 arms), sponsored by Central Denmark Region. Planned start Feb 2025; status: authorised.
02
Drugs
indapamide
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on 2024-516000-41-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516000-41-01.